Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients.
Rousseau C, Ferrer L, Supiot S, Bardiès M, Davodeau F, Faivre-Chauvet A, Baumgartner P, Wijdenes J, Lacombe M, Barbet J, Guillaume T, Moreau P, Harousseau JL, Kraeber-Bodéré F, Cherel M.
Rousseau C, et al.
Tumour Biol. 2012 Jun;33(3):679-88. doi: 10.1007/s13277-012-0362-y. Epub 2012 Mar 3.
Tumour Biol. 2012.
PMID: 22389160